Zobrazeno 1 - 10
of 20 472
pro vyhledávání: '"conjugate vaccine"'
Autor:
Uraguchi K; Department of Epidemiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan; Department of Otolaryngology-Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. Electronic address: pz6b2n7x@s.okayama-u.ac.jp., Matsumoto N; Department of Epidemiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan., Mitsuhashi T; Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan., Takao S; Department of Epidemiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan., Makihara S; Department of Otolaryngology-Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Ando M; Department of Otolaryngology-Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Yorifuji T; Department of Epidemiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Publikováno v:
Vaccine [Vaccine] 2024 Jul 25; Vol. 42 (19), pp. 4081-4087. Date of Electronic Publication: 2024 May 17.
Autor:
von Gottberg A; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: annev@nicd.ac.za., Kleynhans J; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., de Gouveia L; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Tempia S; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Global Influenza Program, World Health Organization, Geneva, Switzerland., Meiring S; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa., Quan V; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa., du Plessis M; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Paediatrics, Kalafong Provincial Tertiary Hospital, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., von Mollendorf C; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Crowther-Gibson P; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa., Avenant T; Department of Paediatrics, Kalafong Provincial Tertiary Hospital, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., du Plessis N; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa., Kularatne R; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Rahima Moosa Mother and Child Hospital, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa., Chibabhai V; Charlotte Maxeke Johannesburg Academic Hospital, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa., Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Wits Infectious Diseases and Oncology Research Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Klugman KP; Pneumonia and Pandemic Prevention, Surveillance and Epidemic Control, Bill & Melinda Gates Foundation, Seattle, WA, USA., Whitney CG; Global Health Institute and Rollins School of Public Health, Emory University, Atlanta, GA, USA., Cohen C; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: cherylc@nicd.ac.za.
Publikováno v:
The Lancet. Global health [Lancet Glob Health] 2024 Sep; Vol. 12 (9), pp. e1470-e1484.
Autor:
Mohanty S; Merck Research Laboratories, Merck & Co. Inc, Rahway, NJ, USA., Tsai JH; Evidence & Access, OPEN Health, Bethesda, MD, USA., Ning N; Evidence & Access, OPEN Health, Newton, MA, USA., Martinez A; Evidence & Access, OPEN Health, Bethesda, MD, USA., Verma RP; Evidence & Access, OPEN Health, Bethesda, MD, USA., Heisen M; Evidence & Access, OPEN Health, Rotterdam, The Netherlands., Weaver J; Merck Research Laboratories, Merck & Co. Inc, Rahway, NJ, USA., Feemster KA; Merck Research Laboratories, Merck & Co. Inc, Rahway, NJ, USA., Chun B; Merck Research Laboratories, Merck & Co. Inc, Rahway, NJ, USA., Weiss TW; Merck Research Laboratories, Merck & Co. Inc, Rahway, NJ, USA., Schmier JK; Evidence & Access, OPEN Health, Bethesda, MD, USA.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2325745. Date of Electronic Publication: 2024 Apr 02.
Autor:
Belman S; Parasites and Microbes, Wellcome Sanger Institute, Hinxton, UK. sophie.belman@sanger.ac.uk.; Department of Genetics, University of Cambridge, Cambridge, UK. sophie.belman@sanger.ac.uk.; Global Health Resilience, Earth Sciences Department, Barcelona Supercomputing Center, Barcelona, Spain. sophie.belman@sanger.ac.uk., Lefrancq N; Department of Genetics, University of Cambridge, Cambridge, UK., Nzenze S; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa., Downs S; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., du Plessis M; Department of Clinical Microbiology and Infectious Diseases, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa., Lo SW; Parasites and Microbes, Wellcome Sanger Institute, Hinxton, UK.; Milner Centre for Evolution, Department of Life Sciences, University of Bath, Bath, UK., McGee L; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Department of Science and Technology/National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., von Gottberg A; Department of Clinical Microbiology and Infectious Diseases, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; Division of Medical Microbiology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Bentley SD; Parasites and Microbes, Wellcome Sanger Institute, Hinxton, UK., Salje H; Department of Genetics, University of Cambridge, Cambridge, UK.
Publikováno v:
Nature [Nature] 2024 Jul; Vol. 631 (8020), pp. 386-392. Date of Electronic Publication: 2024 Jul 03.
Autor:
Alfvén T; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.; Sachs' Children and Youth Hospital, South General Hospital, Stockholm, Sweden., Bennet R; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden., Granath A; Department of Clinical Sciences, Intervention and Technology, Division of ENT Diseases, Karolinska Institutet, Stockholm, Sweden.; Department of ENT Diseases, Karolinska University Hospital, Stockholm, Sweden., Dennison SH; Department of Clinical Sciences, Intervention and Technology, Division of ENT Diseases, Karolinska Institutet, Stockholm, Sweden., Eriksson M; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
Publikováno v:
Acta paediatrica (Oslo, Norway : 1992) [Acta Paediatr] 2024 Apr; Vol. 113 (4), pp. 764-770. Date of Electronic Publication: 2024 Jan 12.
Autor:
Perdrizet J; Global Value and Evidence, Pfizer Canada, Kirkland, QC, Canada., Wilson M; RTI Health Solutions, Research Triangle Park, North Carolina, USA., Wannaadisai W; Global Value and Evidence, Pfizer Ltd, Tadworth, UK., Apodaca K; Vaccines, Global Medical Affairs, Pfizer Inc, New York, USA., Grant L; Vaccines, Global Medical Affairs, Pfizer Inc, New York, USA.
Publikováno v:
Expert review of vaccines [Expert Rev Vaccines] 2024 Jan-Dec; Vol. 23 (1), pp. 879-886. Date of Electronic Publication: 2024 Oct 09.
Autor:
Shincy MR; Central Research Laboratory, Kempegowda Institute of Medical Sciences, Bangalore, India.; Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed-to-be University), Bangalore, India., Vandana G; Central Research Laboratory, Kempegowda Institute of Medical Sciences, Bangalore, India., Akhila MM; Central Research Laboratory, Kempegowda Institute of Medical Sciences, Bangalore, India., Shilpa R; Central Research Laboratory, Kempegowda Institute of Medical Sciences, Bangalore, India., Ravikumar KL; Central Research Laboratory, Kempegowda Institute of Medical Sciences, Bangalore, India.
Publikováno v:
Bioanalysis [Bioanalysis] 2024 Feb; Vol. 16 (4), pp. 191-201. Date of Electronic Publication: 2024 Feb 05.
Autor:
Ryman J; Quantitative Pharmacology and Pharmacometrics, Rahway, NJ, USA., Sachs JR; Quantitative Pharmacology and Pharmacometrics, Rahway, NJ, USA., Yee KL; Quantitative Pharmacology and Pharmacometrics, Rahway, NJ, USA., Banniettis N; Clinical Research, Rahway, NJ, USA., Weaver J; Center for Observational and Real-World Evidence,Merck & Co, Inc, Rahway, NJ, USA., Weiss T; Center for Observational and Real-World Evidence,Merck & Co, Inc, Rahway, NJ, USA.
Publikováno v:
Expert review of vaccines [Expert Rev Vaccines] 2024 Jan-Dec; Vol. 23 (1), pp. 60-68. Date of Electronic Publication: 2023 Dec 14.
Autor:
Yildirim I; Department of Pediatrics, Section of Infectious Diseases and Global Health, Yale University School of Medicine, New Haven, Connecticut.; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut.; Yale Institute for Global Health, Yale University, New Haven; Connecticut.; Yale Center for Infection and Immunity, Yale University, New Haven, Connecticut., Lapidot R; Division of Pediatric Infectious Diseases, Rambam Health Care Campus, Haifa, Israel.; Department of Pediatrics, Section of Infectious Diseases, Boston University, Chobanian and Averdisian School of Medicine, Boston, Massachusetts., Shaik-Dasthagirisaheb YB; Department of Pediatrics, Section of Infectious Diseases, Boston University, Chobanian and Averdisian School of Medicine, Boston, Massachusetts., Hinderstein S; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut., Lee H; Department of Pediatrics, Section of Infectious Diseases and Global Health, Yale University School of Medicine, New Haven, Connecticut., Klevens M; Massachusetts Department of Public Health, Boston, Massachusetts., Grant L; Pfizer Inc., New York, New York., Arguedas Mohs AG; Pfizer Inc., New York, New York., Cane A; Pfizer Inc., New York, New York., Madoff L; Massachusetts Department of Public Health, Boston, Massachusetts., Johnson H; Massachusetts Department of Public Health, Boston, Massachusetts., Ivanof C; Massachusetts Department of Public Health, Boston, Massachusetts., Burns M; Massachusetts Department of Public Health, Boston, Massachusetts., Pelton S; Department of Pediatrics, Section of Infectious Diseases, Boston University, Chobanian and Averdisian School of Medicine, Boston, Massachusetts.
Publikováno v:
Pediatrics [Pediatrics] 2024 Jan 01; Vol. 153 (1).
Autor:
Adamkiewicz TV; Department of Family Medicine, Morehouse School of Medicine, Atlanta, GA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA., Yee MEM; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA., Thomas S; Department of Medicine, Emory University School of Medicine, Atlanta, GA.; Georgia Emerging Infections Program, Atlanta, GA.; Atlanta Veterans Administration Health System, Decatur, GA., Tunali A; Department of Medicine, Emory University School of Medicine, Atlanta, GA.; Atlanta Veterans Administration Health System, Decatur, GA., Lai KW; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA.; University of California, Davis, CA., Omole FS; Department of Family Medicine, Morehouse School of Medicine, Atlanta, GA., Lane PA; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA., Yildirim I; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA.; Department of Pediatrics, Yale University School of Medicine, New Haven, CT.; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT.; Yale Center for Infection and Immunity, Yale Institute of Global Health, New Haven, CT.
Publikováno v:
Blood advances [Blood Adv] 2023 Nov 14; Vol. 7 (21), pp. 6751-6761.